Maria Luisa Vazquez-Villegas

Maria Luisa Vazquez-Villegas

Auto-generated profile, based on publicly available information

Maria Luisa Vazquez-Villegas

Unidad de Medicina Familiar No., 4, Departamento de Epidemiologia, Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Mexico

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VDValeria Diaz-Rizo
Valeria Diaz-Rizo
DBDavid Bonilla-Lara
David Bonilla-Lara
LGLaura Gonzalez-Lopez
Laura Gonzalez-Lopez
DSDalia Sanchez-Mosco
Dalia Sanchez-Mosco
NFNicte S. Fajardo-Robledo
Nicte S. Fajardo-Robledo
JGJorge I. Gamez-Nava
Jorge I. Gamez-Nava
There are controversial results about the role of serum leptin and adiponectin levels as biomarkers of the severity of proteinuria in lupus nephritis. The aim of this study was to evaluate the relationship between serum leptin and adiponectin levels with severity of proteinuria secondary to lupus nephritis (LN). In a cross-sectional study, 103 women with systemic lupus erythematosus (SLE) were evaluated for kidney involvement. We compared 30 SLE patients with LN, all of them with proteinuria, versus 73 SLE patients without renal involvement (no LN). A comprehensive set of clinical and laboratory variables was assessed, including serum levels of leptin and adiponectin by ELISA. Multivariate analyses were used to adjust for potential confounders associated with proteinuria in LN. We found higher adiponectin levels in the LN group compared with the no LN group (20.4 ± 10.3 vs 15.6 ± 7.8 μg/mL; p = 0.02), whereas no differences were observed in leptin levels (33.3 ± 31.4 vs 22.5 ± 25.5 ng/mL; p = 0.07). Severity of proteinuria correlated with an increase in adiponectin levels (r = 0.31; p = 0.001), but no correlation was observed with leptin. Adiponectin levels were not related to anti-dsDNA or anti-nucleosome antibodies. In the logistic regression, adiponectin levels were associated with a high risk of proteinuria in SLE (OR = 1.06; 95% CI 1.01–1.12; p = 0.02). Instead, leptin was not associated with LN. These findings indicate that adiponectin levels are useful markers associated with proteinuria in LN. Further longitudinal studies are required to identify if these levels are predictive of renal relapse.

27 February 2017 in Clinical and Experimental Medicine
Verified
Journal Article
Closed access
PDF file
Edsaul Emilio Perez-GuerreroEdsaul Emilio Perez-Guerrero
Edsaul Emilio Perez-Guerrero
JGJorge Ivan Gamez-Nava
Jorge Ivan Gamez-Nava
JMJose Francisco Muñoz-Valle
Jose Francisco Muñoz-Valle
EMErnesto German GERMAN Cardona Muñoz
Ernesto German GERMAN Cardona Muñoz
DBDavid Bonilla-Lara
David Bonilla-Lara
LLLaura Gonzalez Lopez
Laura Gonzalez Lopez

24 May 2016 in Scandinavian Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
JGJi Gamez-Nava
Ji Gamez-Nava
LCLf de la Cerda-Trujillo
Lf de la Cerda-Trujillo
MVMl Vazquez-Villegas
Ml Vazquez-Villegas
FCF Cons-Molina
F Cons-Molina
MAMf Alcaraz-Lopez
Mf Alcaraz-Lopez
LLLaura Gonzalez Lopez
Laura Gonzalez Lopez
Objectives: To compare bone turnover marker (BTM) levels and bone mineral density (BMD) between patients with ankylosing spondylitis (AS) and healthy controls (HC) and to evaluate, in AS, the association between BTM levels and clinical variables, spinal syndesmophytes, and BMD using multivariate analysis. Method: Seventy-eight AS patients were compared with 58 HC matched by gender. Spinal syndesmophytes in AS and other characteristics were assessed. C-terminal telopeptide fragments of type I collagen (CTX), bone-specific alkaline phosphatase (BAP), osteocalcin (OC) serum levels, and BMD of the lumbar spine, femoral neck, and forearm were evaluated. Results: AS males and females had lower BAP levels than their respective HC (p < 0.001 and p = 0.001). AS patients with bridging syndesmophytes had higher OC levels than AS patients either with non-bridging syndesmophytes (p = 0.001) or without spinal syndesmophytes (p < 0.001). OC and CTX levels correlated significantly with the modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS). In the multivariate linear regression adjusted by age, gender, the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), BMD in the lumbar spine, and C-reactive protein (CRP), we observed an association between BAP levels and anti-tumour necrosis factor (anti-TNF) use (p = 0.05) whereas OC levels were associated with mSASSS (p < 0.001) and anti-TNF use (p = 0.05), and CTX levels were exclusively associated with mSASSS (p = 0.03). In the logistic regression analysis, only OC levels were associated with the presence of syndesmophytes in AS [odds ratio (OR) 2.42, 95% confidence interval (CI) 1.19–5.75]. Conclusions: We observed an increase in OC levels in AS patients with syndesmophytes. BTM levels were associated with the severity of spinal damage. Future longitudinal studies should evaluate whether these BTMs should be included as tools to determine the prognosis and progression of spinal damage.

23 May 2017 in Journal of International Medical Research
Verified
Journal Article
Open access
LGLaura Gonzalez-Lopez
Laura Gonzalez-Lopez
NFNicte S. Fajardo-Robledo
Nicte S. Fajardo-Robledo
ASA. Miriam Saldaña-Cruz
A. Miriam Saldaña-Cruz
IMInocente V. Moreno-Sandoval
Inocente V. Moreno-Sandoval
DBDavid Bonilla-Lara
David Bonilla-Lara
JGJorge I. Gamez-Nava
Jorge I. Gamez-Nava
Objective: To identify correlations of the serum leptin, adiponectin, interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) concentrations with the clinical characteristics, presence of spinal syndesmophytes, and body composition in patients with ankylosing spondylitis (AS). Methods: Forty-eight patients with AS were compared with 41 sex- and age-matched controls. Assessment included clinical characteristics and the presence of spinal syndesmophytes. The serum leptin, adiponectin, TNF-α, and IL-6 concentrations were determined. Body composition was evaluated using dual-energy X-ray absorptiometry. Results: Patients with AS and controls had similar fat mass and lean mass. Patients with AS had higher serum TNF-α and leptin concentrations than controls (52.3 vs. 1.5 pg/mL and 17.2 vs. 9.0 µg/mL, respectively). The IL-6 and adiponectin concentrations were not significantly different between the two groups. Patients with syndesmophytes had higher leptin concentrations than those without syndesmophytes (22.1 vs. 10.9 µg/mL); this difference remained after adjustment for the body mass index. Conclusion: Elevated leptin concentrations are associated with spinal radiographic damage in patients with AS and can serve as a biomarker. Future studies should evaluate whether leptin might be a potential target for treatments to avoid structural damage.

1 January 2017 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
CNC. A. Nava-Valdivia
C. A. Nava-Valdivia
ASA. M. Saldaña-Cruz
A. M. Saldaña-Cruz
ECE. G. Corona-Sanchez
E. G. Corona-Sanchez
JSJessica Murillo Saich
Jessica Murillo Saich
María Cristina Morán MoguelMaría Cristina Morán Moguel
María Cristina Morán Moguel
JGJorge I. Gamez-Nava
Jorge I. Gamez-Nava
Osteoporosis (OP) is highly prevalent in rheumatoid arthritis (RA) and is influenced by genetic factors. Single-nucleotide polymorphism (SNP) rs2073618 in the TNFRSF11B osteoprotegerin (OPG) gene has been related to postmenopausal OP although, to date, no information has been described concerning whether this polymorphism is implied in abnormalities of bone mineral density (BMD) in RA. We evaluated, in a case-control study performed in Mexican-Mestizo women with RA, whether SNP rs2073618 in the TNFRSF11B gene is associated with a decrease in BMD. RA patients were classified as follows: (1) low BMD and (2) normal BMD. All patients were genotyped for the rs2073618 polymorphism by PCR-RFLP. The frequency of low BMD was 74.4%. Higher age was observed in RA with low BMD versus normal BMD (62 and 54 years, resp.; p<0.001). Worse functioning and lower BMI were observed in RA with low BMD (p=0.003 and p=0.002, resp.). We found similar genotype frequencies in RA with low BMD versus RA with normal BMD (GG genotype 71% versus 64.4%, GC 26% versus 33%, and CC 3% versus 2.2%, resp.; p=0.6). We concluded that in Mexican-Mestizo female patients with RA, the rs2073618 polymorphism of the TNRFS11B gene is not associated with low BMD.

31 March 2012 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
LLLaura Gonzalez Lopez
Laura Gonzalez Lopez
JRJaime Morales Romero
Jaime Morales Romero
MVM. Luisa Vazquez-Villegas
M. Luisa Vazquez-Villegas
RVRebeca Villa-Manzano
Rebeca Villa-Manzano
ARAlberto D. Rocha-Muñoz
Alberto D. Rocha-Muñoz
JGJorge I. Gamez-Nava
Jorge I. Gamez-Nava